Search Results - "Rougemont, A.L."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    A novel biocompatible hyaluronic acid–chitosan hybrid hydrogel for osteoarthrosis therapy by Kaderli, S., Boulocher, C., Pillet, E., Watrelot-Virieux, D., Rougemont, A.L., Roger, T., Viguier, E., Gurny, R., Scapozza, L., Jordan, O.

    Published in International journal of pharmaceutics (10-04-2015)
    “…[Display omitted] A conventional therapy for the treatment of osteoarthrosis is intra-articular injection of hyaluronic acid, which requires repeated, frequent…”
    Get full text
    Journal Article
  2. 2

    Do NK Cells Contribute to the Pathophysiology of Transplant‐Associated Thrombotic Microangiopathy? by Ansari, M., Vukicevic, M., Rougemont, A. L., Moll, S., Parvex, P., Gumy‐Pause, F., Chalandon, Y., Passweg, J., Ozsahin, H., Roosnek, E.

    Published in American journal of transplantation (01-08-2011)
    “…Transplant‐associated thrombotic microangiopathy (TA‐TMA) is a life‐threatening complication caused by the aggregation of platelets exposed to the thrombogenic…”
    Get full text
    Journal Article
  3. 3

    Intérêt de l’élastographie ARFI dans les cholestases néonatales/infantiles by Hanquinet, S., Courvoisier, D.S., Rougemont, A.L., Wildhaber, B., Anooshiravani, M., McLin, V.

    “…Les enfants avec atrésie des voies biliaires (AVB) développent rapidement une fibrose hépatique secondaire à la destruction inflammatoire des voies biliaires…”
    Get full text
    Journal Article